January 2025 in “ARC Journal of Dermatology” Black patients are underrepresented in alopecia research, highlighting the need for more inclusive studies.
March 2020 in “Section 5: Patient safety and quality assurance” Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.
165 citations
,
September 2013 in “Contemporary Clinical Trials” Aesthetic rehabilitation techniques can improve life quality and wellbeing for disabled patients.
March 2024 in “Clinical, cosmetic and investigational dermatology” Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.
1 citations
,
September 2023 in “Journal of the American Academy of Dermatology” Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.
September 2015 in “Fluids and Barriers of the CNS” Three skull models were found most useful for testing hydrocephalus valve programming.
23 citations
,
December 2006 in “Evaluation and Program Planning” The document suggests a new model for evaluating public research that better captures the full value of knowledge creation and use, using PCOS research as an example.
10 citations
,
November 2022 in “Protein & Cell” Quercetin significantly helps hair growth by activating hair follicles and improving blood vessel formation around them.
January 2025 in “Investigative and Clinical Urology” SHPro® improved urinary symptoms and erectile function in men and is safe.
14 citations
,
June 2021 in “British journal of dermatology/British journal of dermatology, Supplement” Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.
January 2008 in “The New England Journal of Medicine” Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.
September 2003 in “Journal of the Royal Society of Medicine” The document concludes that while some advocate for a patient voucher system, it may be unequal and current healthcare reforms should be given a chance, and it also recommends various medical books for their comprehensive coverage and advice on specific health issues.
3 citations
,
May 2024 in “Cureus” Laser hair removal improves life quality short-term for women with PCOS-related hirsutism.
February 2026 in “BMJ Open” The impact of virtual care on health and privacy is unclear and may be biased.
May 2008 in “Trends in Urology Gynaecology & Sexual Health” Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.
May 2015 in “HAL (Le Centre pour la Communication Scientifique Directe)” APIs' stability is influenced by crystalline forms, pressure, and water.
March 2024 in “Hair transplant forum international” The document's conclusion cannot be summarized because the content is not accessible or understandable.
Photobiomodulation improves the quality of life for people with hair loss.
2 citations
,
January 2000 in “Quaternary Science Reviews” April 2024 in “Journal of the European Academy of Dermatology and Venereology”
2 citations
,
February 2020 in “Rivista Urologia” Both terazosin and baclofen effectively reduce pain in young men with chronic testicular pain, with no difference in their effectiveness.
January 1995 in “Expert Systems with Applications” January 2004 in “Zhongguo yaoke daxue xuebao” Two finasteride preparations are bioequivalent.
2 citations
,
November 2023 in “International Journal of Preventive Medicine and Health (IJPMH)” The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.
2 citations
,
March 2025 in “Archives of Dermatological Research” Negative views about alopecia worsen quality of life and increase anxiety and depression.
October 2024 in “Open Repository of the University of Porto (University of Porto)” Pharmacists play a crucial role in personalized care and medication management.
December 2021 in “Innovation in aging” Frailer men have a higher risk of worsening prostate problems and serious health events needing hospital care.
12 citations
,
February 2019 in “Journal of patient-reported outcomes” Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.
Most patients were satisfied with topical finasteride, and few experienced side effects.